Works matching DE "ISOCITRATE dehydrogenase"


Results: 1382
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Treatment of IDH-mutant glioma in the INDIGO era.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00646-2
    By:
    • Lin, Mathew D.;
    • Tsai, Alexander C.-Y.;
    • Abdullah, Kalil G.;
    • McBrayer, Samuel K.;
    • Shi, Diana D.
    Publication type:
    Article
    16

    Distinct aneuploid evolution of astrocytoma and glioblastoma during recurrence.

    Published in:
    NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00453-1
    By:
    • Zhang, Jinsen;
    • Feng, Yuan;
    • Li, Guanghao;
    • Zhang, Jianhua;
    • Zhang, Xin;
    • Zhang, Yi;
    • Qin, Zhiyong;
    • Zhuang, Dongxiao;
    • Qiu, Tianming;
    • Shi, Zhifeng;
    • Zhu, Wei;
    • Zhang, Rui;
    • Wu, Yonghe;
    • Liu, Haikun;
    • Cao, Dandan;
    • Hua, Wei;
    • Mao, Ying
    Publication type:
    Article
    17
    18
    19
    20

    MRI-Based Deep Learning Method for Classification of IDH Mutation Status.

    Published in:
    Bioengineering (Basel), 2023, v. 10, n. 9, p. 1045, doi. 10.3390/bioengineering10091045
    By:
    • Bangalore Yogananda, Chandan Ganesh;
    • Wagner, Benjamin C.;
    • Truong, Nghi C. D.;
    • Holcomb, James M.;
    • Reddy, Divya D.;
    • Saadat, Niloufar;
    • Hatanpaa, Kimmo J.;
    • Patel, Toral R.;
    • Fei, Baowei;
    • Lee, Matthew D.;
    • Jain, Rajan;
    • Bruce, Richard J.;
    • Pinho, Marco C.;
    • Madhuranthakam, Ananth J.;
    • Maldjian, Joseph A.
    Publication type:
    Article
    21
    22

    Characterization of the human IDH1 gene promoter.

    Published in:
    AIMS Molecular Science, 2023, v. 10, n. 3, p. 186, doi. 10.3934/molsci.2023013
    By:
    • Yutaka Takihara;
    • Ryuji Otani;
    • Takuro Ishii;
    • Shunsuke Takaoka;
    • Yuki Nakano;
    • Kaori Inoue;
    • Larsen, Steven;
    • Yoko Ogino;
    • Masashi Asai;
    • Sei-ichi Tanuma;
    • Fumiaki Uchiumi
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Temozolomide based treatment in glioblastoma: 6 vs. 12 months.

    Published in:
    Oncology Letters, 2024, v. 28, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14551
    By:
    • Fasano, Morena;
    • Pirozzi, Mario;
    • De Falco, Vincenzo;
    • Miceli, Chiara Carmen;
    • Farese, Stefano;
    • Zotta, Alessia;
    • Famiglietti, Vincenzo;
    • Vitale, Pasquale;
    • Di Giovanni, Ilaria;
    • Brancati, Christian;
    • Carfora, Vincenzo;
    • Solari, Domenico;
    • Somma, Teresa;
    • Cavallo, Luigi Maria;
    • Cappabianca, Paolo;
    • Conson, Manuel;
    • Pacelli, Roberto;
    • Ciardiello, Fortunato;
    • Addeo, Raffaele
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Novel canine isocitrate dehydrogenase 1 mutation Y208C attenuates dimerization ability.

    Published in:
    Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12214
    By:
    • Kawakami, Shota;
    • Michishita, Masaki;
    • Sakaue, Motoharu;
    • Morimatsu, Masami;
    • Uemura, Mitsuki;
    • Kashiwagi, Nobuaki;
    • Maeda, Marika;
    • Machida, Yukino;
    • Azakami, Daigo;
    • Egusa, Ai S.;
    • Onozawa, Eri;
    • Ishioka, Katsumi;
    • Watanabe, Masami;
    • Tanaka, Yoshikazu;
    • Omi, Toshinori;
    • Ochiai, Kazuhiko
    Publication type:
    Article
    46
    47
    48
    49
    50